Solventum Corp | SOLV - Cost Of Sales

Stock Price
78.12
Daily Change
1.14 1.48%
Monthly
-7.27%
Yearly
6.46%
Q1 Forecast
74.60

Solventum Corp reported $963M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
Baxter International USD 1.88B 66M Sep/2025
Becton, Dickinson and Co. USD 5.19B 2.32B Sep/2025
Cencora USD 80.77B 3.02B Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
Insulet USD 196.2M 700K Sep/2025
Solventum Corp USD 963M 23M Sep/2025
West Pharmaceutical Services USD 510.3M 17.7M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025